NCT01768715

Brief Summary

Patients with alcoholic hepatitis non-responsive to steroids have a poor prognosis. Recently a French-Belgian prospective study has obtained good results (acceptable survival with a low rate of alcohol recidivism). The hypothesis of the present study is that carefully selected Spanish patients with alcoholic hepatitis that do not respond to steroid therapy may have a good survival if they receive a liver transplant. The expected rate of alcohol recidivism in such a selected population will be low.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Geographic Reach
1 country

17 active sites

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2012

Completed
3 days until next milestone

Study Start

First participant enrolled

January 1, 2013

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 15, 2013

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

June 3, 2014

Status Verified

June 1, 2014

Enrollment Period

1.9 years

First QC Date

December 29, 2012

Last Update Submit

June 2, 2014

Conditions

Keywords

Alcoholic hepatitisLiver transplantationSurvivalAlcoholism

Outcome Measures

Primary Outcomes (1)

  • Evaluate survival of patients with severe alcoholic hepatitis non responsive to therapy after liver transplantation

    The survival of patients transplanted with alcoholic hepatitis is going to be compared with the survival of patients with alcoholic hepatitis that are not considered adequate for liver transplantation

    1 year after the diagnosis of alcoholic hepatitis

Secondary Outcomes (4)

  • Evaluate the applicability of liver transplantation in patients with alcoholic hepatitis non responsive to steroid therapy

    1 year

  • Evaluate the mortality in waiting list for transplantation of patients with alcoholic hepatitis unresponsive to steroid therapy

    1 year

  • Evaluate the rate of alcohol recidivism after liver transplantation for alcoholic hepatitis

    1, 2, 3, 4 and 5 years

  • Evaluate survival of patients with alcoholic hepatitis after liver transplantation.

    2, 3, 4 and 5 years after the diagnosis of alcoholic hepatitis

Study Arms (3)

Good response

Patients with severe alcoholic hepatitis and good response to therapy.

Non transplant candidates

Patients with severe alcoholic hepatitis and poor response to therapy, that are not candidates to transplantation, according to the specified criteria.

Transplant candidates

Patients with severe alcoholic hepatitis and poor response to therapy, that are candidates to transplantation, according to the specified criteria.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with alcoholic hepatitis participating in this trial are going to be selected from patients admitted to the hospital (from the emergency department or referred from other hospital)

You may qualify if:

  • Diagnosis of alcoholic hepatitis (liver biopsy will be advisable).
  • First episode of clinical decompensation of alcoholic liver disease (defined as jaundice, variceal bleeding, ascites or portal-systemic encephalopathy).
  • Absence of a high risk of alcoholic recidivism (according to De Gottardi, et al).
  • Severe alcoholic hepatitis (ABIC score \> 6.71)
  • Informed consent

You may not qualify if:

  • Age over 65 years.
  • Hepatitis B or C or HIV infections.
  • Uncontrolled bacterial infection
  • Other liver diseases, such as alpha-1-antitrypsin deficiency, primary biliary cirrhosis, ...
  • Morbid obesity (BMI \> 35 kg/m2)
  • Major uncontrolled psychiatric disease
  • Drug addiction (excluding tobacco) in the last two years.
  • Absence of informed consent.
  • Acute-on-chronic liver disease.
  • Paracetamol consumption over 10 grams in the last week.
  • Criteria for liver transplantation.
  • Absence of response to steroid therapy (Lille score ≥ 0.45 7 days after initiation of steroid therapy).
  • Adequate social and familiar environment.
  • Complete agreement in the medical staff about the candidate to transplantation.
  • Absence of bacterial or fungal infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (17)

Hospital Vall d'Hebrón

Barcelona, Barcelona, Spain

Location

Hospital Marqués de Valdecilla

Santander, Cantabria, Spain

Location

Hospital Reina Sofía

Córdoba, Córdoba, Spain

Location

Hospital Virgen de la Nieves

Granada, Granada, Spain

Location

Complejo Hospitalario Universitario de la Coruña

A Coruña, La Coruña, Spain

Location

Hospital Clínico Universitario de Santiago

Santiago de Compostela, La Coruña, Spain

Location

Hospital Gregorio Marañón

Madrid, Madrid, Spain

Location

Hospital Ramón y Cajal

Madrid, Madrid, Spain

Location

Hospital Puerta de Hierro

Majadahonda, Madrid, Spain

Location

Hospital Virgen de la Arrixaca

Murcia, Murcia, Spain

Location

Hospital Carlos Haya

Málaga, Málaga, Spain

Location

Clínica Universidad de Navarra

Pamplona, Navarre, Spain

Location

Hospital Central de Asturias

Oviedo, Principality of Asturias, Spain

Location

Hospital Virgen del Rocío

Seville, Sevilla, Spain

Location

Hospital La Fe

Valencia, Valencia, Spain

Location

Hospital Río Hortega

Valladolid, Valladolid, Spain

Location

Hospital Lozano Blesa

Zaragoza, Zaragoza, Spain

Location

Related Publications (4)

  • Dominguez M, Rincon D, Abraldes JG, Miquel R, Colmenero J, Bellot P, Garcia-Pagan JC, Fernandez R, Moreno M, Banares R, Arroyo V, Caballeria J, Gines P, Bataller R. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol. 2008 Nov;103(11):2747-56. doi: 10.1111/j.1572-0241.2008.02104.x. Epub 2008 Aug 21.

    PMID: 18721242BACKGROUND
  • Tome S, Martinez-Rey C, Gonzalez-Quintela A, Gude F, Brage A, Otero E, Abdulkader I, Forteza J, Bustamante M, Varo E. Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease. J Hepatol. 2002 Jun;36(6):793-8. doi: 10.1016/s0168-8278(02)00047-8.

    PMID: 12044530BACKGROUND
  • Wells JT, Said A, Agni R, Tome S, Hughes S, Dureja P, Lucey MR. The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation. Liver Transpl. 2007 Dec;13(12):1728-35. doi: 10.1002/lt.21298.

    PMID: 18044757BACKGROUND
  • Mathurin P, Moreno C, Samuel D, Dumortier J, Salleron J, Durand F, Castel H, Duhamel A, Pageaux GP, Leroy V, Dharancy S, Louvet A, Boleslawski E, Lucidi V, Gustot T, Francoz C, Letoublon C, Castaing D, Belghiti J, Donckier V, Pruvot FR, Duclos-Vallee JC. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2011 Nov 10;365(19):1790-800. doi: 10.1056/NEJMoa1105703.

    PMID: 22070476BACKGROUND

MeSH Terms

Conditions

Hepatitis, AlcoholicAlcoholism

Condition Hierarchy (Ancestors)

HepatitisLiver DiseasesDigestive System DiseasesLiver Diseases, AlcoholicAlcohol-Induced DisordersAlcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Ignacio Herrero, MD

    Clinica Universidad de Navarra

    STUDY CHAIR
  • Santiago Tome, MD

    Complejo Hospitalario Universitario de Santiago

    STUDY CHAIR
  • Ignacio Gonzalez-Pinto, MD

    Hospital Central de Asturias

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2012

First Posted

January 15, 2013

Study Start

January 1, 2013

Primary Completion

December 1, 2014

Study Completion

December 1, 2017

Last Updated

June 3, 2014

Record last verified: 2014-06

Locations